$14.18
+0.22 (+1.58%)
Open$13.94
Previous Close$13.96
Day High$14.30
Day Low$13.93
52W High$21.26
52W Low$13.54
Volume—
Avg Volume78.9K
Market Cap182.92M
P/E Ratio—
EPS$-2.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+174.6% upside
Current
$14.18
$14.18
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.20M | 22.28M | 84.88M |
| Net Income | -27,039,001 | -28,237,527 | 12.73M |
| Profit Margin | -140.8% | -133.8% | 15.0% |
| EBITDA | -27,341,725 | -30,139,984 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -13.8% | -13.8% | +19.4% |
| Debt/Equity | 0.20 | 0.20 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |